NP/PA 24-Hour Waiver Training - AANP
- Registration Closed
ASAM, AANP and AAPA have formed a collaborative to provide the 24-hour waiver training for nurse practitioners and physician assistants. Educational content has been identified and/or created to satisfy the 24-hour requirement as described in the Comprehensive Addiction and Recovery Act (CARA).
To qualify to prescribe medications for Opioid Use Disorder, NPs and PAs must:
• Be licensed under state law to prescribe Schedule III, IV, or V medications for pain
• Complete not less than 24 hours of appropriate education through a qualified provider
• Through other training or experience, demonstrate the ability to treat and manage OUD
• If required by state law, be supervised or work in collaboration with a qualifying physician to prescribe medications for the treatment of OUD
**The content was originally developed for the 8-hour DATA2000 training for physicians. This content is now offered to NPs/PAs and appropriate provider language will be changed as content continues to evolve.
This training is presented in two parts. Part I is the 8-hour training for physicians, NPs and PAs. Part II is the additional 16 hours for NPs/PAs required by CARA. In Part II, you will see the topics listed in CARA with specific content under those topics.
Before you begin and to receive AANP CE Credit, you must register through the AANP CE Center. Click here to register.
Once registration is complete on the AANP CE Center, return to the ASAM e-Learning Center to begin and/or continue the content.
The collaborative of ASAM, AANP and AAPA identified and reviewed this content to provide the NP/PA training required by CARA.
The NP/PA 24-Hour Waiver Training is available for free through 2018 in part by an unrestricted educational grant from Indivior.
The 16-hour product developed includes all additional education required by the Comprehensive Addiction and Recovery Act (CARA) for nurse practitioners to successfully apply for a waiver to prescribe buprenorphine for office-based treatment of opioid use disorders.
This activity is approved for 24.0 contact hour(s) of continuing education (which includes 18.0 hours of pharmacology) by the American Association of Nurse Practitioners. Activity ID 16122474. This program was planned in accordance with AANP CE Standards and Policies and AANP Commercial Support Standards.
Please ensure that your state regulations allow you to prescribe buprenorphine and other medications to treat OUD before you apply for the waiver. Some states may have overriding state legislation that will prevent NPs and PAs from prescribing these medications even if Federal law allows it.
- Fill out the Waiver Notification Form on SAMHSA’s website.
- Submit copies of your training certificate(s) to SAMHSA by email: firstname.lastname@example.org or fax: 301.576.5237.
SAMHSA reviews waiver applications within 45 business days of receipt. If approved, you will receive a letter via email that confirms your waiver and includes your prescribing identification number.
Waiver applications are forwarded to the DEA. DEA regulations require your prescribing identification number to be included on all buprenorphine prescriptions for opioid dependency treatment, along with your regular DEA number.
If you have not received confirmation of receipt of your application, or if it has been more than 45 business days since submitting it, contact CSAT by email: email@example.com or call 866.287.2728.
To qualify for a waiver to treat patients with Opioid Use Disorder, NPs and PAs must:
- Be licensed under state law to prescribe schedule III, IV, or V medications for pain
- Complete no less than 24 hours of appropriate education through a qualified provider or through other training or experience, demonstrate the ability to treat and manage OUD
- If required by state law, supervision or working in collaboration with a qualifying physician (physician must be waivered) to prescribe medications for the treatment of OUD may be required.
Download this helpful FAQ for technical issues.